# Sprott Physical Platinum & Palladium Trust: financial statements, quarterly

SPPP · NYSE · CIK 1539190 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/sppp.md) · [Financials](/companies/sppp/financials.md) · [Filings](/companies/sppp/filings.md) · [Insiders](/companies/sppp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sppp/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.7](/filings/0001558370-18-002502.md) | [0.3](/filings/0001558370-19-002640.md) | [0.0](/filings/0001558370-20-003397.md) | [0.1](/filings/0001558370-21-003333.md) | [0.3](/filings/0001387131-22-003799.md) | [1.2](/filings/0001387131-23-003844.md) | [0.9](/filings/0001999371-24-003927.md) | [0.4](/filings/0001999371-25-002919.md) | [0.6](/filings/0001999371-26-005825.md) | [0.3](/filings/0001999371-26-005825.md) | [12.0](/filings/0001999371-26-005825.md) |
| Total assets | $m | not reported | [104](/filings/0001558370-18-002502.md) | [125](/filings/0001558370-19-002640.md) | [102](/filings/0001558370-20-003397.md) | [118](/filings/0001558370-21-003333.md) | [127](/filings/0001387131-22-003799.md) | [132](/filings/0001387131-23-003844.md) | [138](/filings/0001999371-24-003927.md) | [117](/filings/0001999371-25-002919.md) | [168](/filings/0001999371-26-005825.md) | [781](/filings/0001999371-26-005825.md) |
| Total liabilities | $m | not reported | [0.3](/filings/0001558370-18-002502.md) | [0.2](/filings/0001558370-19-002640.md) | [0.2](/filings/0001558370-20-003397.md) | [0.3](/filings/0001558370-21-003333.md) | [0.2](/filings/0001387131-22-003799.md) | [0.6](/filings/0001387131-23-003844.md) | [0.1](/filings/0001999371-24-003927.md) | [0.2](/filings/0001999371-25-002919.md) | [0.3](/filings/0001999371-26-005825.md) | [8.8](/filings/0001999371-26-005825.md) |
| Shareholders' equity | $m | [96.2](/filings/0001558370-18-002502.md) | [104](/filings/0001558370-19-002640.md) | [125](/filings/0001558370-20-003397.md) | [102](/filings/0001558370-21-003333.md) | [118](/filings/0001387131-22-003799.md) | [127](/filings/0001387131-23-003844.md) | [132](/filings/0001999371-24-003927.md) | [138](/filings/0001999371-25-002919.md) | [116](/filings/0001999371-26-005825.md) | [167](/filings/0001999371-26-005825.md) | [772](/filings/0001999371-26-005825.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 43,566,837 at 2025-12-31, from the cover of the [40-F filed 2026-03-16](/filings/0001999371-26-005825.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.